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As evidence-based practice has become an important issue in healthcare settings, the educational needs
for knowledge and skills for the generation and utilization of healthcare evidence are increasing. Sys-
tematic review (SR), a way of evidence generation, is a synthesis of primary scientiﬁc evidence, which
summarizes the best evidence on a speciﬁc clinical question using a transparent, a priori protocol driven
approach. SR methodology requires a critical appraisal of primary studies, data extraction in a reliable
and repeatable way, and examination for validity of the results. SRs are considered hierarchically as the
highest form of evidence as they are a systematic search, identiﬁcation, and summarization of the
available evidence to answer a focused clinical question with particular attention to the methodological
quality of studies or the credibility of opinion and text. The purpose of this paper is to introduce an
overview of the fundamental knowledge, principals and processes in SR. The focus of this paper is on SR
especially for the synthesis of quantitative data from primary research studies that examines the
effectiveness of healthcare interventions. To activate evidence-based nursing care in various healthcare
settings, the best and available scientiﬁc evidence are essential components. This paper will include
some examples to promote understandings.
Copyright © 2016, Korean Society of Nursing Science. Published by Elsevier. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Evidence-based practice (EBP) is an important element in pa-
tient safety and quality of healthcare. The landmark report from the
Institute of Medicine, Crossing the Quality Chasm: A New Health
System for the 21st Century, described a healthcare system that is
highly disintegrated and lacking care coordination [1]. The
Roundtable on Evidence-Based Medicine from the Institute of
Medicine has been called to help transform the way evidence on
clinical effectiveness is generated and used to improve health and
healthcare. Participants have set a goal that, by the year 2020, 90.0%
of clinical decisions will be supported by accurate, timely, and up-
to-date clinical information, and will reﬂect the best available ev-
idence [2]. Quickly following these reports, recommendations were
made in the Quality Chasm series that underscored the centrality of
EBP as a solution in redesigning care that is effective and safe [1e3].
The EBP movement was signiﬁcantly accelerated by these reports,lege of Nursing, Mo-Im Kim
Yonsei-ro, Seodaemun-gu,
ciety of Nursing Science. Publishedand key recommendations were made, which were (a) to provide
services based on scientiﬁc knowledge to all who could beneﬁt [1],
(b) to educate all healthcare professionals to deliver evidence-
based care [3] and (c) to assess effectiveness of clinical services to
provide unbiased information about what really works in health-
care [2].
EBP is a problem-solving approach to patient care that in-
corporates the conscientious use of current best evidence available
from well-designed research studies, clinical expertise and
assessment. Patient values and preferences are also incorporated
within a caring context [4e7]. According to Joanna Briggs Institute
(JBI) model of EBP, evidence-based healthcare is a cyclical process.
Global healthcare needs, as identiﬁed by clinicians or patients/
consumers, are addressed through the generation of research evi-
dence that is effective, feasible, appropriate and meaningful to
speciﬁc populations, cultures and settings. This evidence is
collected and the results are appraised, synthesized and transferred
to service delivery settings and health professionals who utilize it
and evaluate its impact on health outcomes, health systems and
professional practice. Therefore, in order to work in and use
healthcare systems globally, one should consider evidence gener-
ation, different forms of evidence in a formal assessment called aby Elsevier. This is an open access article under the CC BY-NC-ND license (http://
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mation in appropriate, relevant formats to inform health systems,
health professionals and consumers (evidence transfer), and
effective implementation of evidence and evaluation of its impact
on healthcare practice (evidence utilization) [8].
As implementation of EBP has become a core competency
among healthcare professional in promoting high-quality, patient-
centered healthcare, the need for acquisition of skills in evidence
generation and utilization has increased. Several organizations
have contributed to the preparation of systematic reviews,
including the National Institute of Health and Clinical Excellence in
the UK, the Evidence-based Practice Center Program, funded by the
Agency for Healthcare Research and Quality in the United States,
the JBI, and the International Campbell and Cochrane Collabora-
tions, with the latter being the largest single producer of systematic
reviews in healthcare, with more than 5,200 published by the end
of 2015 (Cochrane Collaboration). Often, healthcare providers and
policy makers are overwhelmed with an unmanageable amount of
information, including evidence from healthcare research. There is
a need for time, skills and resources to ﬁnd, appraise and interpret
this evidence and to incorporate it into healthcare decisions.
Therefore, the purposes of this paper are to introduce concept
and characteristics of SR, and to explain major steps in synthesizing
quantitative evidences suggested by the JBI and Cochrane meth-
odology in conducting SR.
Deﬁnition and characteristic of SR
SR, which is also called “research synthesis” is an attempt to
integrate empirical data for the purpose of uncovering interna-
tional evidence and producing statements about that evidence to
guide decision making. SR requires explicit and exhaustive
reporting of the methods used in synthesis [9,10]. The character-
istics of SR are (a) protocol-driven process, (b) clearly stated set of
objectives with predeﬁned eligibility criteria for studies, (c) explicit
and reproducible methodology, (d) systematic search that attempts
to identify all studies that would meet the eligibility criteria, (e)
assessment of the validity of the ﬁndings of the included studies,
and (f) systematic presentation, and synthesis, of the characteristics
and ﬁndings of the included studies [11]. SRs have become the
“gold standard” in the synthesis of literature at each evidential
level, as they enable rigorous, transparent and replicable analysis of
all relevant study results [12]. The most common type of clinical
questions for SR is the treatment effectiveness and the synthesis of
data from randomized controlled trials in quantitative studies [10].
However, other types of quantitative research such as quasiexper-
imental, cohort, and cross-sectional studies can be valuable for SR
in nursing care.
SRsprovidea reliableestimatebecause theyare required to follow
strict scientiﬁc design based on explicit, prespeciﬁed and reproduc-
ible methods. They can also provide insights as to where knowledge
is lacking which provides guidance for future research [13].
Methodological process for conducting SR
Review title of SR
The title of the SR protocol should be as descriptive as is
reasonable and reﬂect relevant information. If the review aims to
examine clinical effectiveness, this should be stated in the title. If
speciﬁc interventions and/or patient outcomes are to be examined,
these should also be included. If possible, the setting and target
population should also be stated [14], for example, “A systematic
review of the effectiveness of lifestyle interventions for improving
bone health in women at high risk of osteoporosis” [15]. Thisexample provides readers with an indication of the population,
“women at high risk of osteoporosis”, the interventions, “lifestyle
interventions”, and the outcome of interest, “bone health”, as well
as the fact that it is a SR. Ensuring the relevant ﬁelds of the Popu-
lation, Intervention, Comparison intervention, Outcomes (PICO)
reminder are incorporated in the title assists peer reviewers as well
as end users to identify the scope and relevance of the review.
Developing a review question
Sackett et al [7] stated that a good clinical question should have
four essential factors: (a) the patient or problem in question; (b) the
intervention, test, or exposure of interest; (c) comparison in-
terventions (if relevant); (d) the outcome, or outcomes, of interest.
It should be clear, directly focused on the problem at hand, and
answerable by searching the medical literature [16]. The clinical
question in PICO format aims to clarify its purpose and is used to
deﬁne the properties of studies to be considered for inclusion in the
review. PICO is used to construct a clear and meaningful question
when searching for quantitative evidence [17].
Population within a speciﬁc setting within a speciﬁc time frame
should be described in the clinical questions for SR [17]. There are
no subgroups or exclusions described, thus all patients meeting the
described criteria would be included in the analysis for each
outcome. Speciﬁc reference to population characteristics, either for
inclusion or exclusion should be based on a clear, scientiﬁc justiﬁ-
cation rather than based on unsubstantiated clinical, theoretical or
personal reasoning [17].
Interventions of interest are nursing care, treatment, or expo-
sure. The intervention should be described in detail, particularly if it
is complicated. Consideration should also be given towhether there
is a risk of exposure to the intervention in comparator groups in the
included primary studies [17].
Comparison is being made with the intervention of interest. For
JBI reviews of effectiveness, the comparator is the one element of
the PICO mnemonic that can be either left out of the questions, or
posited as a generalized statement. SR of effectiveness based on the
inclusive deﬁnition of evidence adopted by JBI often seeks to
answer broader questions about complex interventions [17]. Usu-
ally there are active and passive comparators. Active comparators
are speciﬁc comparators of one’s interest. For example, if one is
interested in comparing clinical effectiveness of different types of
exercise such as aerobic exercise versus nonaerobic exercise in
metabolic syndrome, the nonaerobic exercise group can be an
active comparator. Otherwise, passive comparator is a current
status or placebo comparator. For example, if one is interested in
knowing the effectiveness of exercise, the types of passive
comparator can be a group with no exercise or maintaining usual
daily activities of life.
Outcomes are the measures of effectiveness of the intervention.
The protocol should list all the outcome measures presented in the
study. The relevance of each outcome to the review objective
should be apparent from the background section. Outcomes should
bemeasurable and appropriate to the objective of the SR. It is useful
to list outcomes and identify them as primary or secondary, short-
term or absolute and discuss which ones will be included. It is also
important to consider and include nursing outcomes for both cli-
ents’ perspectives such as functional status and/or quality of life,
and those of the nursing professionals such as nurses’ satisfaction.
Developing a search strategy: a guide to evidence-based
information retrieval
After formulating the clinical question with the format of PICO,
the next step is to search for the relevant evidence that will help
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that, even in countries where hospitals have facilities for internet
access allowing healthcare personnel access to a number of elec-
tronic databases, many people are not familiar with the process of
carrying out efﬁcient search [18,19]. Effective search aims to
maximize the potential of retrieving relevant articles within the
shortest possible time.
The ﬁrst step for searching is a plan for optimal search strategies.
Careful consideration is required in searching, such as different
spelling (e.g., American spelling or British English spelling), syno-
nyms, and plurals. Also, when constructing the search, it is good to
break up the search question, and not to overcomplicate the search
by including too many terms. Using MeSH/EMTREE terms, which
are internationally acknowledged, is the way to search for best
evidence.
In quantitative research, the aim is usually to establish changes
in the other variable (experimental studies), and/or imply a corre-
lation or association between variables (observational studies). For
the best available evidence, study design (e.g., SRs, RCTs, qua-
siexperimental studies, cohort studies), or the level of evidence
should be considered. For instance, if one is interested in knowing
the effectiveness of exercise on metabolic syndrome, studies con-
ducted using RCTs, experimental design, or quasiexperimental
design should be included in the search.
Searching for evidence is a three-step process: (a) exploratory
search; (b) implement a standardized tested search strategy within
each selected database; (c) review the reference list of retrieved
studies. Prior to commencing SR it is important to search the
existing SR libraries to ensure that the review being planned has
not already been conducted or is currently being updated. (e.g., The
Cochrane Library, JBI Library of Systematic Reviews and the Centre
for Reviews and Dissemination).
The comprehensiveness of searching and documenting the da-
tabases searched is a core component of the SR’s credibility. In
addition to databases of published research, there are several on-
line sources of grey or unpublished literature that should be
considered. Grey literature is a term that refers to papers, reports,
technical notes or other documents produced and published by
governmental agencies, academic institutions and other groups
that are not distributed or indexed by commercial publishers. Many
of these documents are difﬁcult to locate and obtain. Rather than
compete with the published literature, grey literature has the po-
tential to complement and communicate ﬁndings to a wider
audience, as well as to reduce publication bias.
Critical appraisal of retrieved evidences
Critical appraisal is a process for increasing the effectiveness of
reading, by encouraging systematic assessment of reports of
research evidence to see which ones can best answer clinical
problems and inform “best practice” [20]. Researchers should
appraise critically because combing results of poor quality research
may lead to biased or misleading estimates of effectiveness [10].
Therefore, the aim of critical appraisal is to establish validity and to
establish the risk of bias [10]. In critical appraisal, the primary
reviewer and the secondary reviewer should discuss what is
considered acceptable to the needs of the review in terms of the
speciﬁc study characteristics. The reviewers should be clear on
what constitutes acceptable levels of information to allocate a
positive appraisal being compared with a negative appraisal, or an
appraisal of “unclear” or “not applicable”. This discussion should
take place before independently conducting the appraisal. Selec-
tion of tools for critical appraisal need to be based on the study
design. There are a variety of gold standard checklists and tools
available to assess the validity of studies. Most of these tools use aseries of criteria that can be scored as beingmet, notmet or unclear.
The decision as to whether or not to include a study can be made
based on meeting a predetermined proportion of all criteria, or on
certain criteria being met. It is also possible to weight the different
criteria differently, for example blinding of assessors (to prevent
detection bias) may be considered twice as important as blinding
the caregivers (to prevent performance bias). It is important that
appraisal tools are appropriate for the design of the study; this is so
that the questions of the tool are speciﬁc to that study design [14].
The decisions about the scoring system and the cut-off for inclusion
should be made in advance, and be agreed upon by all participating
reviewers before commencing the critical appraisal.
Ranking the quality of evidence on effectiveness is to what
extent the study design minimizes bias or demonstrates validity.
Hierarchy of evidence is most often used, with levels of quality
equated with speciﬁc study designs [10]. RCTs are the “gold stan-
dard” for primary study design uponwhich to base decisions on the
effectiveness of healthcare interventions, but they are not neces-
sarily appropriate, or ethical, to answer other questions [21]. In
RCTs, the most commonly used tool for critical appraisal is
Cochrane’s “Risk of bias” table. The standard “Risk of bias” table
includes (a) random sequence generation (selection bias), (b)
allocation concealment (selection bias), (c) blinding of participants
and personnel (performance bias), (d) blinding of outcome
assessment (detection bias), (e) incomplete outcome data (attrition
bias) and (f) other bias. For each item, the table provides a
description of what was reported to have happened in the study
and a subjective judgement regarding protection from bias (“Yes”
for a low risk of bias, “No” for a high risk of bias; “Unclear” other-
wise) [22].
Data extraction
Data extraction refers to the process of identifying and recording
relevant details from the original (e.g. primary) research studies
that will be included in the SR. A standardized extraction tool is
used to minimize the risk of error when extracting data. Other
error-minimizing strategies include ensuring that both reviewers
have practiced using the extraction tool and can apply the tool
consistently. It is also recommended that reviewers extract data
independently before conferring. This process include details of the
types of data extracted from the included studies, as predetermined
in the protocol. If no datawas available for particular outcomes, one
can consider contacting the corresponding author, or discuss it in
the review. The included studies may include several outcomes;
however the review should focus on extracting information related
to the research questions and outcomes of interest. Information
that may impact the generalizability of the review ﬁndings such as
studymethod, setting and population characteristics should also be
extracted and reported. Population characteristics include factors
such as age, past medical history, comorbidities, complications or
other potential confounders. JBI-MAStARI reduces errors in data
extraction by using two independent reviewers and a standardized
data extraction instrument [17]. The data extracted will vary
depending on the review question. However, it will generally either
be dichotomous or continuous in nature. Dichotomous data will
include the number of participants with the exposure/intervention
(n) and the total sample (N) for both control and treatment groups.
Classically, this is stated as n/N; therefore therewill be two columns
of data for each outcome of interest. For continuous data, the mean
and standard deviation, plus sample size are extracted for each
speciﬁed outcome for both the control and intervention (or expo-
sure) group. Typically, this is expressed as “M (SD)/n”where n is the
sample size for the particular group. If only the standard error (SE)
is reported, SD can be calculated from SE, as long as the sample size
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SD¼ SE  √n.
In some cases it may not be possible to extract all necessary raw
data from an included study for the SR, as sometimes only aggre-
gated data are reported, or perhaps data from two different patient
populations have been combined in the data analysis, and the re-
view needs to focus on only one of the patient populations. In these
circumstances, the standard approach is to make contact with the
authors of the publication and seek their assistance in providing the
raw data. Most researchers are obliging when it comes to these
requests provided that records are still available. If the study’s au-
thors do not respond or if the data is unavailable, this should be
noted in the report. In addition to the data, conclusions that study
authors have drawn based on the data are also extracted. It is useful
to identify the study authors’ conclusions and establish whether
there is agreement with the conclusions made by the authors of the
SR.Data synthesis
Extracted data should be synthesized for the next process. A
synthesis can either be descriptive (narrative synthesis) or statis-
tical (meta-analysis). If the data is heterogeneous and presented as
a narrative summary, potential sources of heterogeneity should be
discussed (e.g., clinical, methodological or statistical) as well as on
what basis it was determined inappropriate to combine the data
statistically [10]. Also, it is important to combine the studies in an
appropriate manner using methods appropriate to the speciﬁc type
and nature of data that has been extracted. The methods of syn-
thesis should be congruent with the description of the type of data
for extraction. Therefore, data synthesis should describe the spe-
ciﬁc types of data and effect measures used [10]. Statistical com-
bination of study data provides a summary estimate, using
transparent rules speciﬁed in advance [23].
This allows the overall effect of a treatment/intervention to be
determined. Although the ultimate aim for a quantitative SR is to
combine study data in meta-analysis, this is not always appropriate
or possible. Data from two or more separate studies are required to
generate a synthesis. Studies to be included in the meta-analysis
should be similar to each other so that generalization of results is
valid. The three main areas surrounding data that should be
considered when deciding whether or not to combine data are (a)
clinicaldare the patient characteristics similar (e.g., age, diagnoses,
comorbidities, treatments)? (b) methodologicalddo the studies
use the same study design and measure the same outcomes? (c)
statisticaldwere outcomes measured in the same way, at the same
time points, using comparable scales? When considering con-
ducting a meta-analysis, the statistical methods and software (e.g.,
JBI-MAStARI or Cochrane-RevMan) can be used. Also, effect size
which describes the relationship between two variables and is
represented by a square on a forest plot, and heterogeneity which is
the amount of variation in the characteristics of included studies
should be considered [10].Reporting and evaluation of SR
There is no standardized international approach to structuring
how the ﬁndings of reviews will be reported. The audience for the
review should be considered when structuring and writing up the
ﬁndings. Meta-view graphs represent a speciﬁc item of analysis
that can be incorporated into the results section of a review.
However, the results aremore than themeta-view graphs.Whether
it is structured based on the intervention of interest, or some other
structure, the content of this section needs to present the resultswith clarity using the available tools (meta-view graphs, tables,
ﬁgures) supported by textual descriptions.
The results section should be framed in such a way that as a
minimum, the following ﬁelds are described in the protocol as
either planned for reporting, or given consideration by the re-
viewers in preparing their SR report as per the following example:
number of studies identiﬁed; number of retrieved studies; number
of studies matching preferred study design (i.e., RCTs); number and
design of other types of studies; number of appraised studies;
number of excluded studies and overview of reasons for exclusion;
number of included studies. These results are commonly written in
narrative style, and also illustrated with a ﬂow diagram.
Systematic reviews should follow a logical, linear process. Flaws
in their presentation in peer-reviewed journals led to the estab-
lishment of the Preferred Items for Reporting Systematic Reviews
and Meta-analyses (PRISMA) reporting guidelines [24]. An exten-
sion of the PRISMA statement has been developed for protocols
(PRISMA-P). PRISMA-P is intended to guide the development of
protocols of systematic reviews and meta-analyses evaluating
therapeutic efﬁcacy. PRISMA-P is meant to be used primarily by
authors preparing systematic review protocols for publication,
public consumption, or otherwise. PRISMA-P is also used for jour-
nal editors and peer reviewers gauging the adequacy of review
protocols for publication [25].
In addition, the “assessment of multiple systematic reviews” is
also used for evaluation of methodological quality of SR [26]. It
contains 11 items including the following: (a) was an a priori design
provided? (b) was there duplicate study selection and data
extraction? (c) was a comprehensive literature search performed?
(d) was the status of publication (i.e., grey literature) used as an
inclusion criterion? (e) was a list of studies (included and excluded)
provided? (f) were the characteristics of the included studies pro-
vided? (g) was the scientiﬁc quality of the included studies assessed
and documented? (h) was the scientiﬁc quality of the included
studies used appropriately in formulating conclusions? (i) were the
methods used to combine the ﬁndings of studies appropriate? (j)
was the likelihood of publication bias assessed? (k) was the conﬂict
of interest stated? [26]
Discussion
SR protocol is important because it allows reviewers (a) to plan
carefully and thereby anticipate potential problems, (b) to explicitly
document what is planned before they start their review; (c) to
prevent arbitrary decision making with respect to inclusion criteria
and extraction of data; and (d) to reduce redundancy of efforts and
enhance collaboration, when available.
This paper was written to provide an introductory guide to
reliably, transparently and rigorously conduct SRs on the effects of
healthcare interventions. It also includes an extensive discussion
and description of the parameters for meta-analysis, what the
process is, what the necessary considerations related to ensuring
that the meta-analysis is conducted appropriately and with trans-
parency are. Importantly the limitations of meta-analysis are dis-
cussed, and directions on how to interpret and use the results of a
meta-analysis even where the results are potentially confounded
by statistical heterogeneity. These are essential considerations and
the new reviewer needs to be aware that a metaview graph is not
the end of the task. The graph needs to be interpreted appropri-
ately, and further investigation may be necessary.
As this is an introductory text and/or educational article for SR,
the discussion in this paper ﬁnishes not with methods for meta-
analysis, but with more pragmatic directions and recommenda-
tions on how to write up a completed review report. The guidance
in this section is mostly based on the processes developed and used
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highly standardized methods that are associated with high quality
syntheses for the new reviewer, the student, or those looking for
introductory information on methods. There are also numerous
other texts on this topic, however in this paper an introduction to
the most acceptable and standardized procedures of SR is provided.
Sometimes it may be a challenge for nurses to generate evidence
through rigorous review methods. Therefore, collaborative efforts
among nurses, synthesis scientists, and information professionals
are recommended for conducting a transparent and qualiﬁed SR.
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